Lung Cancer

Category

Positive Study Ongoing Study Data from AMG 510 in Patients with Previous Treated KRAS G12C-Mutated Solid Tumors

Amgen (AMGN) announced new data from its ongoing Phase I clinical trial evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors. AMG 510 is a first-in-class investigational oral therapy designed to selectively and irreversibly target the...

University of PA Study Reveals Pembrolizumab Can Lengthen Progression-Free Survival in Non-Small Cell Lung Cancer

University of Pennsylvania investigators report that the administration of pembrolizumab behind locally ablative therapy (LAT) for oligometastatic non-small cell lung cancer (NSCLC) seems to lengthen progression-free survival (PFS) without degradation of quality of...

Giorgio V. Scaglioti Presents the 5 Ps in Changing Translational Research in NSCLC: Future Prospects

A new precision medicine-driven digital infrastructure, collaborative in nature and inclusive of various research centers, new biomarkers, oncology detection strategies, immunotherapies and system biology toolsets—needs to be synchronized and packaged for rapid...

Lung Cancer Rates Rising Across Asia

Of the 1.8 million killed by lung cancer worldwide in 2018, 61.4% passed in the Asia Pacific region according to a recent report. 59.% of the world’s new lung cancer cases are found in the same region. Across ASEAN member states, lung cancer recorded a total of...

Pin It on Pinterest